Author Archive: BIOtechNOW Editor

NCATS SBIR Announces Funding For Biotechs and Small Business Technology Development

lab_tech

The NIH National Center for Advancing Translational Sciences (NCATS) is seeking qualified applicants for its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. NCATS, which offers $17.6 million annually through these programs, has issued a call for applications for two funding opportunities: Contract funding to support small businesses and venture-backed technology development, due Nov. 5, 2014. Investigator-initiated grant funding,due Dec. 5, 2014. NCATS’ SBIR and STTR programs are engines of innovation Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

ALS Ice Bucket Challenge Brings Attention to the Need For Private Funding

rpavich

The ALS Ice Bucket Challenge – the social media phenomenon in which people post videos of themselves dumping buckets of water on their heads – has swept through social media like wildfire as part of an effort to raise both awareness and funding for ALS research. It’s pretty safe to say that it’s working.  As of Thursday morning, the ALS Association had received $41.8 million from existing donors and more than 739,000 new donors over Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Jim Greenwood Talks 21st Century Cures with Chairman Fred Upton

21st-Century-Cures--Free

Recently, BIO CEO and President Jim Greenwood sat down with House Energy and Commerce Chairman Fred Upton (R-MI) to talk about the Committee’s 21st Century Cures initiative, which seeks to “determine what steps we can take to ensure we are taking full advantage of the advances this country has made in science” to speed and improve drug discovery, development and delivery.  This is a bipartisan effort Chairman Upton and the committee are undertaking with the Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

Is Regulatory Transformation for Alzheimer’s Therapies Needed?

Mary Canady

BIO 2014′s  session titled ” Regulatory Transformation: As Alzheimer’s Disease Science, Research and Advocacy Move Toward Earlier Detection and Intervention, How Will Researchers Adapt to this Evolution?” discussed progress and challenges facing researchers and the collaborative efforts between the Food and Drug Administration (FDA) and patient advocacy groups to help them find a cure. The discussion centered on recent FDA Draft Guidance for Early Stage Alzheimer’s Disease Drug Development which allows for an accelerated approval Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Excerpts From Top Ten Current Science Trends Talk

biotech Primer

For the opening day of BIO 2014, BioTech Primer delivered a talk on the Top 10 Current Science Trends, Issues, & Advances.  Three of the technologies covered are highlighted below. Genome Editing: We often refer to a person’s genome – his complete set of genes – as a blueprint for life. But sometimes there are errors in this blueprint. Wouldn’t it be great if we could edit the blueprint and correct these errors? We might Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,